Methicillin-resistant Staphylococcus aureus nasal colonization in a department of pediatrics: a cross-sectional study by Francesco Gesualdo et al.
ITALIAN JOURNAL
OF PEDIATRICS
Gesualdo et al. Italian Journal of Pediatrics 2014, 40:3
http://www.ijponline.net/content/40/1/3RESEARCH Open AccessMethicillin-resistant Staphylococcus aureus nasal
colonization in a department of pediatrics: a
cross-sectional study
Francesco Gesualdo1*, Manuela Onori1, Dafne Bongiorno2, Floriana Campanile2, Emanuela Carloni1,
Livia Mancinelli1, Cristina Russo1, Alberto Villani1, Diletta Valentini1, Massimiliano Raponi1, Alberto E Tozzi1
and Stefania Stefani2Abstract
Background: We describe methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage at admission in patients
admitted to a Department of Pediatrics.
Methods: All patients received a nasal swab at admission. A questionnaire was administered and molecular
genetics analyses were performed on all identified MRSA isolates.
Results: We enrolled 785 patients, affected with both acute and chronic diseases. MRSA nasal colonization
prevalence was 1.15% (CI: 0.5607%-2.093%). Methicillin-sensitive Staphylococcus aureus (MSSA) nasal colonization
prevalence at admission was 19.75% (CI 17.07%-22.64%). Only one MRSA isolate carried the SCCmec V variant; all
other isolates carried the SCCmecIV variant. Five out of 9 MRSA-colonized patients had an underlying condition.
Antibiotic therapy in the previous 6 months was a protective factor for both MRSA (OR 0,66; 95% CI: 0,46-0,96) and
MSSA (OR 0,65; 95% CI: 0,45-0,97) colonization. A tendency to statistical significance was seen in the association
between hospitalization in the 6 months prior to admission and MRSA colonization at admission (OR 4,92; 95% CI:
0,97-24,83). No patient was diagnosed with an S. aureus infection during hospitalization.
Conclusions: The majority of our MRSA colonizing isolates have community origins. Nevertheless, most
MRSA-colonized patients had been hospitalized previously, suggesting that strains that circulate in the community
also circulate in hospital settings. Further studies should elucidate the role of children with frequent contact with
health care institutions in the circulation of antibiotic resistant strains between the hospital and the community.
Keywords: Methicillin-resistant Staphylococcus aureus, Nasal carriage, Risk factorsBackground
In the last decade, after an increasing trend in the incidence
of methicillin-resistant Staphylococcus aureus (MRSA) in-
fections in Europe and the United States, both in adults
and in children [1,2], encouraging data on a general reduc-
tion of invasive MRSA infections have been recently re-
ported [3,4]. The proportion of S. aureus isolates identified
as methicillin-resistant is stabilizing or decreasing in most
European countries [5]. Nevertheless, MRSA remains a
public health priority as the proportion of MRSA of all* Correspondence: f.gesualdo@gmail.com
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reproduction in any medium, provided the orS. aureus isolates is still above 25% in 8 out of 28 countries,
mainly in Southern and Eastern Europe, including Italy [5].
Reports on MRSA nasal colonization in children have
shown variable prevalence figures, ranging from 0 to over
20%, with European figures of 3.3% or lower [6]. Most of
the surveys that investigated nasal carriage have been con-
ducted on healthy pediatric populations, or on patients ad-
mitted to Intensive Care Units [7]. Only few studies have
investigated nasal carriage in General Pediatric Wards [8].
MRSA nasal carriers may be at greater risk of develop-
ing an MRSA infection compared to methicillin-sensitive
S. aureus (MSSA) carriers and to non-carriers, in particu-
lar in intensive care unit (ICU) settings [9,10]. Therefore,
programs for preventing MRSA nosocomial transmissional Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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risk patients, isolation of colonized individuals and
decolonization [11,12]. However, a comprehensive evalu-
ation of prevention strategies is still lacking, and some
strategies may have an unexpected impact on colonized
children and their families, possibly leading to a feeling of
social stigma [13].
The objectives of the present study were to assess the
prevalence of MSSA and MRSA nasal colonization
among patients admitted to a pediatric department, to
describe molecular genetic characteristics of the coloniz-
ing isolates, and to identify epidemiological risk factors
associated with MSSA and MRSA nasal colonization.
Methods
Setting
The Bambino Gesù Children’s Hospital, located in Rome,
Italy, is a 607-bed comprehensive medical centre for
pediatric healthcare and research. The Department of
Pediatrics includes 132 beds in one single building divided
into 4 floors by level of assistance.
Study design and patient recruitment
Over a 3-month period between February 8, 2010 and May
14, 2010 we conducted a cross-sectional study enrolling
patients admitted to 3 wards belonging to the Department
of Pediatrics. Children admitted to the wards were affected
by general pediatric acute or chronic illnesses, rheumato-
logic diseases, infectious diseases (excluding HIV), bronch-
opneumopathies, cystic fibrosis, endocrinological diseases
and genetic diseases.
No age or pathology constraints were applied in the
selection of the population. Patients not speaking Italian,
English, Spanish and French were excluded. Written, in-
formed consent was obtained from patients older than
18 years of age, or from parents of patients younger than
18 years of age, together with patient assent, or written,
informed consent if patient was older than 12 years.
Enrolled patients underwent an anterior nasal swab in
one of the nares within 12 h of admission. A questionnaire
was administered to the parents or to the patient to collect
demographic and epidemiological data, including: birth
date, sex, parents’ data (age, level of education and em-
ployment), number of siblings, number of household
members, number of bedrooms, presence of smoking
people at home, presence of domestic animals, presence of
an household member working in a healthcare facility,
current breastfeeding (for children < 2 years), daycare cen-
ter or school attendance, extra-school sport activity (for
children > 4 years), nail biting (for children > 4 years), diag-
nosis of a chronic underlying disease, past diagnosis of
pneumonia or of an invasive infection, emergency room
visit during last 6 months, hospital admission during last 6
months, administration of antibiotic therapy during last 6months, upper respiratory tract infection during last week.
The study was approved by the Bambino Gesù Children’s
Hospital Ethical Committee.
Laboratory methods for S. aureus identification
Samples were collected from anterior nares using the
ESwab (Copan, Brescia, Italy) collection and transport de-
vice, composed of a flocked swab adsorbed into 1.0 ml of
Amies liquid transport medium. For each nasal sample
two aliquots (10 μl each) of ESwab liquid medium were
streaked onto mannitol salt agar, Chapman (bioMérieux,
Marcy l’Etoile, France) and on chromogenic agar MRSASe-
lect (Bio-Rad, Nazareth Eke, Belgium) respectively, and in-
cubated at 37°C for 18–24 h. Colonies grown on Chapman
agar having morphology suggestive of S. aureus, or
mauve in color presumptively MRSA positive on
chromogenic agar were subcultured onto 5% sheep
blood agar. Phenotypical identification was assessed by
Vitek2 system (bioMérieux Marcy l’Etoile, France) ac-
cording to the manufacturer’s instructions.
In vitro susceptibility testing for oxacillin, erythro-
mycin, clindamycin, gentamicin, ciprofloxacin, rifampicin,
trimethoprim-sulfamethoxazole, mupirocin, vancomycin,
teicoplanin (Sigma Chemical, St. Louis, MO, USA) and li-
nezolid (Pfizer, Groton, CT, USA), was further performed
by the broth microdilution method to determine the mini-
mum inhibitory concentrations (MICs), following the
CLSI guidelines. The EUCAST guidelines were also used
for comparison [14,15]. In particular the oxacillin suscepti-
bility was interpreted according to CLSI recommenda-
tions, and in cases of discrepancy susceptibility testing was
repeated.
The penicillin-binding protein (PBP2a) latex agglutin-
ation test (SLIDEX MRSA Detection, bioMérieux Marcy
l’Etoile, France) was used as an additional phenotypic con-
firmatory test for presumptively detected MRSA strains.
PCR and SCCmec typing
Genomic DNA was extracted from all bacterial cultures
and used as a template for amplification.
All isolates were screened for the presence of the
mecA, lukS-PV/lukF-PV genes and ACME-locus. PCR
experiments were carried out following procedures pre-
viously reported [16-18]. The SCCmec (Staphylococcal-
Chromosomal-Cassette mec) types were first determined
by a multiplex-PCR protocol previously described, and
assigned to the corresponding types [19]. Moreover, for
the characterization of the SCCmec IV subtype an alterna-
tive multiplex-PCR protocol was performed [20], the re-
sults were confirmed with other different multiplex-PCR
protocols, focusing on the mec gene complex and the ccr
gene complex [21] and hsdRMS operon [16].
The sequences of the seven housekeeping genes used
for MLST, corresponding to the allelic profile arcC-
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the sequences obtained for all MRSA strains in study with
those in the MLST database http://saureus.mlst.net [22].
All sequence-types (STs) described in the study were de-
posited on the MLST website. PCR products were ana-
lyzed by electrophoresis on 1% or 2% agarose gels (Sigma
Aldrich, Saint Louis Mo, USA).Statistical methods
Sample size calculation was based on the assumption of
a carriage rate of 2%. Around 785 subjects needed to be
screened, in order to estimate the carriage rate with ad-
equate precision (95% confidence intervals between 1%
and 3% for 785 subjects).
Proportions of the social-demographic characteristics
of each group of colonized/not-colonized children were
compared through χ2 or Fisher exact test where appro-
priate. Statistical tests were considered significant at a p-
value <0.05 level.
In order to study the association between potential risk
factors and colonization status at the time of hospital ad-
mission, we performed a univariate analysis through a lo-
gistic regression model in which odds ratios and 95% CI
were calculated. Potential risk factors included in the ana-
lysis as independent variables were all those investigated
in the questionnaire, plus age at admission.
In each model colonization status was included as a
dependent variable, as follows: colonized patients vs
non-colonized; MSSA colonized vs non-colonized pa-
tients and MRSA colonized vs non-colonized patients.
At the univariate level, the analysis was restricted to
children aged ≤4 years for “sport”; ≥ 3 years for “nail bit-
ing”; <2 years for “breastfeeding”.
Variables with a p-value <0.20 at the univariate analysis
were selected to be included in the multivariate analysis
using a logistic regression model, with nasal carriage being
the dependent variable as reported above. Since none of
the variables analyzed on a restricted population at the uni-
variate level had a p value <0.20, the multivariate model in-
cluded the entire population. Statistical software STATA
11 was used for data analysis.Results
Study population
We enrolled 785 patients from 3 pediatric wards of the
Department. Mean age of patients was 4.62 years (me-
dian: 2.66, range: 0.03-27.7), of which 403 (51%) were
males. Other characteristics of the population are re-
ported in Table 1. Among the enrolled patients, no one
had been admitted for a symptomatic S. aureus infection
or was diagnosed with a nosocomial S. aureus infection
during hospitalization.Colonization prevalence and risk factors
At admission, a total of 164 patients (20.89%; 95% CI:
18.16%-23.84%) were colonized by S. aureus; 155 pa-
tients (19.75%; 95% CI: 17.07%-22.64%) were colonized
by MSSA and 9 patients (1.15%; 95% CI: 0.5607%-
2.093%) were colonized by MRSA.
Among the MRSA colonized patients, 5 had an under-
lying condition (mucopolysaccharidosis, arthrogryposis,
neurofibromatosis, type 1 diabetes, osteoid osteoma).
The remaining 4 patients had been admitted with the
following diagnoses: bronchiolitis, rickettsiosis, chicken-
pox, sepsis. Six of the MRSA-colonized patients had
already been hospitalized in the last 6 months. Combin-
ing information on underlying diseases and previous
hospitalizations, 3 out of 9 MRSA colonized patients did
not have risk factors for previous healthcare exposures.
Risk factors for MSSA and MRSA carriage identified
by multivariate analysis are reported in Table 2.
According to the multivariate analysis, compared to
non-colonized patients, MRSA colonized patients were
more likely to have been hospitalized in the previous 6
months. Antibiotic therapy in the last 6 months was
found as a protective factor for MRSA colonization. The
multivariate analysis did not identify age as a risk factor
for MRSA colonization, while MSSA-colonized patients
were more likely to belong to the 6–13 age group com-
pared to non-colonized children.
MRSA antimicrobial susceptibility and molecular
characteristics
Antimicrobial susceptibility and molecular characteris-
tics of the isolates are reported in Table 3.
Nine MRSA were isolated, all characterized by pheno-
typic and molecular methods, as described in the
Methods section.
All isolates were oxacillin resistant, 4/9 were erythro-
mycin resistant, 3/9 ciprofloxacin and rifampicin resist-
ant, 1/9 gentamicin resistant, and only one isolate was
resistant to cotrimoxazole. All strains were susceptible
to clindamycin, mupirocin, linezolid and glycopeptides.
MLST analysis showed 7 different STs associated with
different variants of SCCmec IV and only one with
SCCmec V.
Only 1 strain carried lukS-PV/lukF-PV genes, and did
not harbour the arginine catabolic mobile element
(ACME), associated toUSA300 clone.
Discussion
This study assessed MRSA nasal colonization in a popu-
lation of children admitted to a General Pediatric
Department, including a large group of patients affected
by chronic diseases. Our results show an MSSA nasal
colonization prevalence of 19.75% and an MRSA nasal
colonization prevalence of 1.15%.
Table 1 General characteristics of patients included in the study
MSSA MRSA Not colonized Total
population
Number of patients; N 155 9 621 785
Male; N, % 87 56.1 4 44.4 312 50.2 403 51.3
Age; N, % 0 - 5 95 61.3 8 88.9 459 73.9 562 71.6
6 - 13 52 33.5 1 11.1 121 19.5 174 22.2
> = 14 8 5.2 0 0.0 41 6.6 49 6.2
Parent nationality; N, % Italian 138 89.0 7 77.8 554 89.2 699 89.0
European 6 3.9 1 11.1 27 4.3 34 4.3
Extra-European1 8 5.2 1 11.1 27 4.3 36 4.6
Mixed 3 1.9 0 0.0 14 2.3 16 2.0
Mother’s age, years; mean, SD 36.5 7.1 32.9 5.8 35.8 6.7 35.9 6.8
Father’s age, years; mean, SD 38.8 7.3 37.7 6.0 39.0 7.1 38.9 7.1
Mothers with high school diploma; N, % 111 71.6 4 44.4 464 74.7 579 73.8
Fathers with high school diploma; N, % 96 61.9 6 66.7 412 66.3 514 65.5
Unemployed mothers; N, % 62 40.0 5 55.6 230 37.0 297 37.8
Unemployed fathers; N, % 11 7.1 0 0.0 18 2.9 29 3.7
Presence of underlying illness; N, % 58 37.4 4 44.4 160 25.8 222 28.3
Hospitalization length; mean, SD 6.8 6.8 7.6 7.5 7.0 6.0 7 6.2
1Among the 36 extra-european patients, 20 (56%) originated from Asian countries, 9 (25%) from African countries, 7 (19%) from South American countries.
The only extra-european MRSA colonized patient was from Vietnam.
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investigated by a number of studies, which showed vari-
able prevalence figures and diverse risk factors [7,8,23-27].
Most studies investigated carriage in a healthy pediatric
population [7,25,27]. A smaller number of studies focused
on Intensive Care Units [28,29], or on patients with under-
lying diseases [24]. Few studies investigated colonization
in a general pediatric ward and our study gives new in-
sights on this topic. Two studies [30,31] investigated
MRSA nasal carriage in different hospital departments, in-
cluding a pediatric ward, and in both studies no MRSA
was identified. In a multicenter study carried out inTable 2 Multivariate risk factors for S. aureus, MSSA and MRS
Risk factor
Total N. of patients
with risk factor (n. 785)
N. of patients MSSA
with risk factor (n. 155)
N. o
patients












OR = Odds Ratios; CI = Confidence Intervals.children’s hospitals in Switzerland, one MRSA was identi-
fied in 1,350 investigated patients (prevalence: 0.07%) [8].
We molecularly characterized the 9 MRSA isolates
and demonstrated the presence of different strains with
community or nosocomial origins.
A circulation of the ST8-CAMRSA-IV.a clone in Italy
has been already demonstrated in patients affected by
invasive infections (necrotizing pneumonia, skin and
soft tissue infections, sepsis), always in association with
PVL production. Among the colonizing isolates belong-
ing to the ST8-CAMRSA-IV.a clone, only one carried
the lukS-PV/lukF-PV genes [32].A colonization
MSSA vs negative MRSA vs negative
f MRSA-colonized
with risk factor (n. 09)
OR 95% CI p OR 95% CI p
1 1,77 1,04 2,98 0,034 NS
0 2,67 1,19 5,99 0,017 NS
4 1,56 1,01 2,39 0,043 NS
4 0,65 0,45 0,97 0,034 0,66 0,46 0,96 0,033
6 NS 4,92 0,97 24,83 0,053
Table 3 Patient’s diagnosis, molecular characteristics and antibiotic resistance of MRSA colonizing isolates
Diagnosis ST SCCmec mec-complex ccr-complex PVL OXA E DA CN CIP RD SXT VA TEC LNZ MUP
1 Mucopolysaccharidosis 8 IV.c B A2B2 - R R S S R R R 0,5 0,25 2 1
2 Chickenpox 8 IV.a B A2B2 - R S S S R S S 1 0,25 2 0,25
3 Bronchiolitis 8 IV.a B A2B2 + R S S S S S S 0,5 0,5 2 1
4 Arthrogryposis 22 IV.c B A2B2 - R S S S S S S 1 0,25 2 0,5
5 Neurofibromatosis 1 45 IV.a B A2B2 - R R S S S R S 0,5 1 2 4
6 Type 1 diabetes 15 IV.a B neg - R S S S R S S 0,5 0,25 2 2
7 Osteoid osteoma 5 IV.a B A2B2 - R R S S S S S 1 0,25 4 0,25
8 Rickettsiosis 1 IV.a B A2B2 - R R S R S R S 0,5 0,25 2 1
9 Sepsis 30 V C C - R S S S S S S 0,5 0,25 2 2
OXA, oxacillin; E, erythromycin; DA, clindamycin; CN, gentamicin; CIP, ciprofloxacin; RD, rifampicin; SXT, trimethoprim-sulfamethoxazole; VA, vancomycin;
TEC, teicoplanin; LNZ, linezolid; MUP, mupirocin. R = resistant; S = sensitive.
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in the United States, circulates worldwide in different
countries [33], and in Italy was recently isolated from
pigs (nasal samples and dust samples collected in hold-
ings of breeding and production pigs) [34].
The ST30 clones, with different pulsotype and genetic
characteristics, have been reported in many areas of the
world. This clone was previously described in Italy in a pa-
tient with necrotizing pneumonia, and associated with
SCCmec IV and the lukS-PV/lukF-PV genes [32]. On the
contrary, our isolate carried for the first time SCCmec V
and ccrC type recombinases, and no lukS-PV/lukF-P
genes. This variability in acquiring diverse genetic ele-
ments (SCCmec and PVL-encoding phages) suggested that
this clone, in Italy, has evolved in multiple occasions.
Circulation of the ST45-CAMRSA-IV.a has been re-
cently demonstrated in Cambodian children [35]. Inter-
estingly, our ST45-CAMRSA-IV.a was isolated from a
recently adopted Vietnamese child.
ST22-CAMRSA-IV was previously described as an epi-
demic infective clone in adults (EMRSA 15) [36] and has
been recently isolated on Portuguese public buses [37]. S.
aureus belonging to ST15 have rarely been reported as
methicillin-resistant. One colonizing ST15-MRSA was re-
ported from Africa and ST15 was previously associated with
community-onset MSSA bacteremia among adults in an
Italian study [38,39]. The present study identified one of the
MRSA colonizing isolates showing ST15-SCCmec type IV.
The only ST5 SCCmec IV colonized a child with previ-
ous hospitalizations for an osteid osteoma.
We observed a tendency to statistical significance in the
association between MRSA colonization and hospitalization
in the 6 months prior to the nasal sampling, confirming the
results reported by other authors [40,41]. Nevertheless, the
majority of our MRSA isolates have community origins.
This observation shows that strains that circulate in
the community also circulate in hospital settings. To this
regard, more research is needed to investigate the role of
children that have frequent contacts with health careinstitution (eg. children affected with underlying disease
and chronic conditions) as potential MRSA vectors be-
tween the hospital and the community [6].
According to our findings, use of antibiotics in the 6
months before admission protects from both MSSA and
MRSA carriage. Other authors have previously reported
a protective effect of antibiotic therapy in the last 6
months on MSSA colonization [25,26].
In the complex interaction of factors affecting emer-
gence and spread of multridrug-resistant organisms, anti-
microbials are known to exert a selective pressure on
resistant clones. We found, instead, a protective effect of
antibiotics administered in the previous 6 months on
MRSA colonization. In order to elucidate this result, more
data regarding prescriptions (kind of infection, class of
prescribed antibiotics, days of therapy) would be needed.
Although, this kind of information is easily subject to re-
call bias, therefore we decided not to include it in our
questionnaire. A cohort study with a prospective design
would be needed for appropriately characterizing the ef-
fect of antibiotic use on resistant clones.
Our study has some limitations. First, parents not speak-
ing Italian, English, Spanish and French were not enrolled
in the study. This might have led to an underestimation of
the MRSA carriage prevalence. However, as foreign pa-
tients are a very limited proportion of the total hospital-
ized patients, the effect of this selection bias could be
negligible.
We did not explore colonization in other body sites
(throat, perineum), which could have led to a misclassifi-
cation of colonized patients as non-colonized [42]. An-
other possible limitation is the low number of patients
that were positive to MRSA for which risk factors were
evaluated. Thus, associations found in our study may be
not sufficient to explain the outcome (nasal carriage).
Conclusion
Our findings show that strains that circulate in the com-
munity also circulate in hospital settings: in fact, the
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origins; nevertheless, most MRSA-colonized patients had
been hospitalized previously. More research is needed to
elucidate the role of antibiotic prescriptions in the emer-
gence of MRSA clones, and to analyze the possible role of
children with frequent contact with health care centers
(eg. children affected with chronic diseases) as MRSA vec-
tors between the hospital and the community.
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